DNA Chips, Biochips or DNA microarrays consists of a microscope slide made materials such as glass, silicon chips, and nylon membrane, which is printed with thousands of minute spots. These spots contain a known DNA sequence or gene in an orderly sequence. DNA microarray uses nucleic acid hybridization principle and type of DNA microarrays include cDNA microarrays, Oligo DNA microarrays, BAC microarrays, and SNP microarrays. Applications of DNA chips include study of transcriptomes and proteomes, diagnosis of diseases, identification of microbes, and others
Restraints of the Global DNA/Gene Microarray Market
The high cost involved in R&D of DNA/Gene microarray technology-based products and limited financial support has posed a great challenge to growth of the global DNA/Gene microarray market. Manufacturing complexity of the biochip technology and research and development that is required to bring out innovative biochips in the market results in high costs of these products.
Key features of the study:
This report provides in-depth analysis of the global DNA/Gene microarray market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global DNA/Gene microarray market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc..
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global DNA/Gene microarray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global DNA/Gene Microarray Market, By Type:
oDNA
cDNA
Global DNA/Gene Microarray Market, By Application:
Genomics
Proteomics
Agricultural biology
Environment
Drug R&D
Gene expression and SNP analysis
Cancer/oncology
Others
Global DNA/Gene Microarray Market, By Geography:
North America
By Type
oDNA
cDNA
By Application
Genomics
Proteomics
Agricultural biology
Environment
Drug R&D
Gene expression and SNP analysis
Cancer/oncology
Others
By Country:
U.S.
Canada
Europe
By Type
oDNA
cDNA
By Application
Genomics
Proteomics
Agricultural biology
Environment
Drug R&D
Gene expression and SNP analysis
Cancer/oncology
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Type
oDNA
cDNA
By Application
Genomics
Proteomics
Agricultural biology
Environment
Drug R&D
Gene expression and SNP analysis
Cancer/oncology
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Type
oDNA
cDNA
By Application
Genomics
Proteomics
Agricultural biology
Environment
Drug R&D
Gene expression and SNP analysis
Cancer/oncology
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Type
oDNA
cDNA
By Application
Genomics
Proteomics
Agricultural biology
Environment
Drug R&D
Gene expression and SNP analysis
Cancer/oncology
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type
oDNA
cDNA
By Application
Genomics
Proteomics
Agricultural biology
Environment
Drug R&D
Gene expression and SNP analysis
Cancer/oncology
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Affymetrix, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Illumina, Inc.
Agilent Technologies Inc.
Roche NimbleGen Inc.
Sequenom, Inc.
Biometrix Technology Inc.
LC Sciences
Life Technologies Corp.
Lifegen Technologies LLC
Microarrays Inc.
Like it? Share it!
About the Author
Trupti Joined: March 17th, 2021 Articles Posted: 36